News & Events

Media Coverage

Despite FDA Setback, KemPharm Advancing Prodrug Pipeline
The Bio Report
1/12/2017
KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'
Benzinga
1/12/2017

 

Media Archive »